SEC Comment Letter for Aptevo Therapeutics Inc. (APVO) (CIK 0001671584) (APVO) — Jul 31, 2018

Aptevo Therapeutics Inc. (APVO) (CIK 0001671584)
Date: July 31, 2018 · CIK: 0001671584 · Accession: 0000000000-18-023473

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-37746

Date

July 30, 2018

Author

Jeffrey G. Lamothe

Form

UPLOAD

Company

Aptevo Therapeutics Inc. (APVO) (CIK 0001671584)

Letter

July 30, 2018 Jeffrey G. Lamothe Chief Financial Officer Aptevo Therapeutics Inc. 2401 4th Avenue, Suite 1050 Seattle, Washington 98121 Re:Aptevo Therapeutics Inc. Form 10-K for Fiscal Year Ended December 31, 2017 Filed March 13, 2018 File No. 001-37746 Dear Mr. Lamothe: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Division of Corporation Finance Office of Healthcare & Insurance

Show Raw Text

July 30, 2018
Jeffrey G. Lamothe
Chief Financial Officer
Aptevo Therapeutics Inc.
2401 4th Avenue, Suite 1050
Seattle, Washington 98121
Re:Aptevo Therapeutics Inc.
Form 10-K for Fiscal Year Ended December 31, 2017
Filed March 13, 2018
File No. 001-37746
Dear Mr. Lamothe:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Division of Corporation Finance
Office of Healthcare & Insurance

SecProbe.io